Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	polypeptide N-acetylgalactosaminyltransferase activity	GALNT11 GALNT12 GALNT5	1.95e-05	20	53	3	GO:0004653
GeneOntologyMolecularFunction	acetylgalactosaminyltransferase activity	GALNT11 GALNT12 GALNT5	1.09e-04	35	53	3	GO:0008376
Domain	Ricin_B_lectin	GALNT11 MRC2 GALNT12 GALNT5	6.99e-07	25	53	4	PF00652
Domain	RICIN	GALNT11 MRC2 GALNT12 GALNT5	1.12e-06	28	53	4	SM00458
Domain	RICIN_B_LECTIN	GALNT11 MRC2 GALNT12 GALNT5	1.12e-06	28	53	4	PS50231
Domain	Ricin_B_lectin	GALNT11 MRC2 GALNT12 GALNT5	1.50e-06	30	53	4	IPR000772
Domain	Glycos_transf_2	GALNT11 GALNT12 GALNT5	8.30e-05	30	53	3	PF00535
Domain	Glyco_trans_2-like	GALNT11 GALNT12 GALNT5	8.30e-05	30	53	3	IPR001173
Domain	-	TENM3 APMAP HHIPL1	1.83e-04	39	53	3	2.120.10.30
Domain	6-blade_b-propeller_TolB-like	TENM3 APMAP HHIPL1	3.00e-04	46	53	3	IPR011042
Domain	Ig-like_fold	ILDR2 IL12RB1 BTN3A3 HMCN2 FNDC3A IGSF9B CNTN2 IGSF3	7.88e-04	706	53	8	IPR013783
Domain	fn3	IL12RB1 FNDC3A IGSF9B CNTN2	1.15e-03	162	53	4	PF00041
Domain	IG	ILDR2 BTN3A3 HMCN2 IGSF9B CNTN2 IGSF3	1.19e-03	421	53	6	SM00409
Domain	Ig_sub	ILDR2 BTN3A3 HMCN2 IGSF9B CNTN2 IGSF3	1.19e-03	421	53	6	IPR003599
Domain	IGv	BTN3A3 IGSF9B IGSF3	1.26e-03	75	53	3	SM00406
Domain	-	GALNT11 GALNT12 GALNT5	1.57e-03	81	53	3	3.90.550.10
Domain	V-set	ILDR2 BTN3A3 IGSF9B IGSF3	1.83e-03	184	53	4	PF07686
Domain	FN3	IL12RB1 FNDC3A IGSF9B CNTN2	1.87e-03	185	53	4	SM00060
Domain	Nucleotide-diphossugar_trans	GALNT11 GALNT12 GALNT5	2.00e-03	88	53	3	IPR029044
Domain	FN3	IL12RB1 FNDC3A IGSF9B CNTN2	2.44e-03	199	53	4	PS50853
Domain	Ig_V-set	ILDR2 BTN3A3 IGSF9B IGSF3	2.44e-03	199	53	4	IPR013106
Domain	Homeodomain-like	HOXA13 TCF4 TCF12 NKX2-1 PBX1	2.46e-03	332	53	5	IPR009057
Domain	-	ILDR2 IL12RB1 BTN3A3 FNDC3A IGSF9B CNTN2 IGSF3	2.57e-03	663	53	7	2.60.40.10
Domain	IG_LIKE	ILDR2 BTN3A3 HMCN2 IGSF9B CNTN2 IGSF3	2.58e-03	491	53	6	PS50835
Domain	FN3_dom	IL12RB1 FNDC3A IGSF9B CNTN2	2.91e-03	209	53	4	IPR003961
Domain	Ig-like_dom	ILDR2 BTN3A3 HMCN2 IGSF9B CNTN2 IGSF3	2.91e-03	503	53	6	IPR007110
Domain	-	NCOA3 TCF4 TCF12	3.66e-03	109	53	3	4.10.280.10
Domain	HLH	NCOA3 TCF4 TCF12	3.86e-03	111	53	3	PF00010
Domain	HLH	NCOA3 TCF4 TCF12	4.36e-03	116	53	3	SM00353
Domain	IGc2	HMCN2 IGSF9B CNTN2 IGSF3	4.42e-03	235	53	4	SM00408
Domain	Ig_sub2	HMCN2 IGSF9B CNTN2 IGSF3	4.42e-03	235	53	4	IPR003598
Domain	BHLH	NCOA3 TCF4 TCF12	4.47e-03	117	53	3	PS50888
Domain	bHLH_dom	NCOA3 TCF4 TCF12	4.58e-03	118	53	3	IPR011598
Domain	LDrepeatLR_classA_rpt	PRKCSH C8B	8.53e-03	49	53	2	IPR002172
Domain	LDLa	PRKCSH C8B	8.53e-03	49	53	2	SM00192
Pathway	KEGG_O_GLYCAN_BIOSYNTHESIS	GALNT11 GALNT12 GALNT5	6.98e-05	30	38	3	M6929
Pubmed	The interaction between thymine DNA glycosylase and nuclear receptor coactivator 3 is required for the transcriptional activation of nuclear hormone receptors.	NCOA3 TDG	2.55e-06	2	56	2	19652917
Pubmed	Expression of basic-helix-loop-helix transcription factor ME2 during brain development and in the regions of neuronal plasticity in the adult brain.	TCF4 TCF12	2.55e-06	2	56	2	7984047
Pubmed	The role of E-proteins in B- and T-lymphocyte development.	TCF4 TCF12	2.55e-06	2	56	2	9618760
Pubmed	The Concerted Action of E2-2 and HEB Is Critical for Early Lymphoid Specification.	TCF4 TCF12	2.55e-06	2	56	2	30936870
Pubmed	Distinct requirements for Tcf3 and Tcf12 during oligodendrocyte development in the mouse telencephalon.	TCF4 TCF12 NKX2-1	4.42e-06	20	56	3	37684687
Pubmed	Overexpression of Galnt3 in chondrocytes resulted in dwarfism due to the increase of mucin-type O-glycans and reduction of glycosaminoglycans.	GALNT11 GALNT12 GALNT5	5.96e-06	22	56	3	25107907
Pubmed	The helix-loop-helix gene E2A is required for B cell formation.	TCF4 TCF12	7.63e-06	3	56	2	8001124
Pubmed	Different roles of E proteins in t(8;21) leukemia: E2-2 compromises the function of AETFC and negatively regulates leukemogenesis.	TCF4 TCF12	7.63e-06	3	56	2	30593567
Pubmed	Sequestosome-1/p62 is the key intracellular target of innate defense regulator peptide.	RIPK1 PRKCD	7.63e-06	3	56	2	19850933
Pubmed	Transcription factor E2-2 is an essential and specific regulator of plasmacytoid dendritic cell development.	TCF4 TCF12	7.63e-06	3	56	2	18854153
Pubmed	ALF1, a basic helix-loop-helix transcription factor, maps to mouse chromosome 9.	TCF4 TCF12	7.63e-06	3	56	2	8833258
Pubmed	E2-2 regulates the expansion of pro-B cells and follicular versus marginal zone decisions.	TCF4 TCF12	7.63e-06	3	56	2	17082585
Pubmed	The DNA glycosylase T:G mismatch-specific thymine DNA glycosylase represses thyroid transcription factor-1-activated transcription.	NKX2-1 TDG	7.63e-06	3	56	2	11438542
Pubmed	Murine helix-loop-helix transcriptional activator proteins binding to the E-box motif of the Akv murine leukemia virus enhancer identified by cDNA cloning.	TCF4 TCF12	7.63e-06	3	56	2	1321336
Pubmed	A role for E2-2 at the DN3 stage of early thymopoiesis.	TCF4 TCF12	7.63e-06	3	56	2	18384878
Pubmed	ME1 and GE1: basic helix-loop-helix transcription factors expressed at high levels in the developing nervous system and in morphogenetically active regions.	TCF4 TCF12	7.63e-06	3	56	2	8261111
Pubmed	WTAP enhances the instability of SYTL1 mRNA caused by YTHDF2 in bladder cancer.	SYTL1 YTHDF2	7.63e-06	3	56	2	37933909
Pubmed	B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB.	TCF4 TCF12	7.63e-06	3	56	2	8649400
Pubmed	Loss of the disease-associated glycosyltransferase Galnt3 alters Muc10 glycosylation and the composition of the oral microbiome.	GALNT11 GALNT12 GALNT5	7.81e-06	24	56	3	31882545
Pubmed	Galnt11 regulates kidney function by glycosylating the endocytosis receptor megalin to modulate ligand binding.	GALNT11 GALNT12 GALNT5	7.81e-06	24	56	3	31740596
Pubmed	Human Hand1 basic helix-loop-helix (bHLH) protein: extra-embryonic expression pattern, interaction partners and identification of its transcriptional repressor domains.	TCF4 TCF12	1.52e-05	4	56	2	11802795
Pubmed	Ectopic Meis1 expression in the mouse limb bud alters P-D patterning in a Pbx1-independent manner.	HOXA13 PBX1	1.52e-05	4	56	2	19247936
Pubmed	SCL binds the human homologue of DRG in vivo.	TCF4 TCF12	1.52e-05	4	56	2	9824680
Pubmed	Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma.	TCF4 TCF12	1.52e-05	4	56	2	21771727
Pubmed	Thymine DNA glycosylase is a positive regulator of Wnt signaling in colorectal cancer.	TCF4 TDG	1.52e-05	4	56	2	24532795
Pubmed	The protein ENH is a cytoplasmic sequestration factor for Id2 in normal and tumor cells from the nervous system.	TCF4 TCF12	1.52e-05	4	56	2	16549780
Pubmed	Adducin regulation. Definition of the calmodulin-binding domain and sites of phosphorylation by protein kinases A and C.	PRKCD ADD2	1.52e-05	4	56	2	8810272
Pubmed	Mutation of a lysine residue in a homeodomain generates dominant negative thyroid transcription factor 1.	NCOA3 NKX2-1	1.52e-05	4	56	2	15449938
Pubmed	Mutations affecting the BHLHA9 DNA-binding domain cause MSSD, mesoaxial synostotic syndactyly with phalangeal reduction, Malik-Percin type.	TCF4 TCF12	1.52e-05	4	56	2	25466284
Pubmed	Genomic analysis of transcriptional networks directing progression of cell states during MGE development.	TCF12 NKX2-1	2.54e-05	5	56	2	30217225
Pubmed	Physical and functional interactions between the transcriptional inhibitors Id3 and ITF-2b. Evidence toward a novel mechanism regulating muscle-specific gene expression.	TCF4 TCF12	2.54e-05	5	56	2	8999959
Pubmed	Galnt1 is required for normal heart valve development and cardiac function.	GALNT11 GALNT12 GALNT5	2.72e-05	36	56	3	25615642
Pubmed	O-glycosylation modulates integrin and FGF signalling by influencing the secretion of basement membrane components.	GALNT11 GALNT12 GALNT5	3.74e-05	40	56	3	22643896
Pubmed	Temporal/spatial expression of nuclear receptor coactivators in the mouse lung.	NCOA3 NKX2-1	3.80e-05	6	56	2	11076796
Pubmed	Characterization of ABF-1, a novel basic helix-loop-helix transcription factor expressed in activated B lymphocytes.	TCF4 TCF12	3.80e-05	6	56	2	9584154
Pubmed	The HAND1 basic helix-loop-helix transcription factor regulates trophoblast differentiation via multiple mechanisms.	TCF4 TCF12	3.80e-05	6	56	2	10611232
Pubmed	The E-protein Tcf4 interacts with Math1 to regulate differentiation of a specific subset of neuronal progenitors.	TCF4 TCF12	3.80e-05	6	56	2	17878293
Pubmed	Differential cooperation between dHAND and three different E-proteins.	TCF4 TCF12	3.80e-05	6	56	2	15351717
Pubmed	E2A basic-helix-loop-helix transcription factors are negatively regulated by serum growth factors and by the Id3 protein.	TCF4 TCF12	5.32e-05	7	56	2	8759016
Pubmed	Adducin is an in vivo substrate for protein kinase C: phosphorylation in the MARCKS-related domain inhibits activity in promoting spectrin-actin complexes and occurs in many cells, including dendritic spines of neurons.	PRKCD ADD2	5.32e-05	7	56	2	9679146
Pubmed	A genome-wide association meta-analysis of preschool internalizing problems.	RIPK1 TENM3	5.32e-05	7	56	2	24839885
Pubmed	ID1 and CEBPA coordinate epidermal progenitor cell differentiation.	TCF4 TCF12	5.32e-05	7	56	2	36330928
Pubmed	Phosphorylation sites on tau identified by nanoelectrospray mass spectrometry: differences in vitro between the mitogen-activated protein kinases ERK2, c-Jun N-terminal kinase and P38, and glycogen synthase kinase-3beta.	PHKG1 PRKCD	5.32e-05	7	56	2	10737616
Pubmed	Tangential migration of corridor guidepost neurons contributes to anxiety circuits.	NKX2-1 PRKCD	7.09e-05	8	56	2	28921616
Pubmed	TWIST1 Homodimers and Heterodimers Orchestrate Lineage-Specific Differentiation.	TCF4 TCF12	7.09e-05	8	56	2	32179550
Pubmed	A Hoxa13:Cre mouse strain for conditional gene manipulation in developing limb, hindgut, and urogenital system.	HOXA13 TCF4	7.09e-05	8	56	2	25980463
Pubmed	Assignment of a disintegrin and metalloproteinase domain 10 (Adam10) gene to mouse chromosome 9.	TCF12 ADAM10	7.09e-05	8	56	2	9441766
Pubmed	GSK3 temporally regulates neurogenin 2 proneural activity in the neocortex.	TCF4 TCF12	7.09e-05	8	56	2	22674256
Pubmed	Microtubule-associated protein/microtubule affinity-regulating kinase (p110mark). A novel protein kinase that regulates tau-microtubule interactions and dynamic instability by phosphorylation at the Alzheimer-specific site serine 262.	PHKG1 PRKCD	7.09e-05	8	56	2	7706316
Pubmed	Sgn1, a basic helix-loop-helix transcription factor delineates the salivary gland duct cell lineage in mice.	TCF4 TCF12	7.09e-05	8	56	2	11784080
Pubmed	The regulatory Ser262 of microtubule-associated protein tau is phosphorylated by phosphorylase kinase.	PHKG1 PRKCD	7.09e-05	8	56	2	8999860
Pubmed	E protein dosage influences brain development more than family member identity.	TCF4 TCF12	7.09e-05	8	56	2	18214987
Pubmed	Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments.	PHKG1 PRKCD	7.09e-05	8	56	2	10090741
Pubmed	Phosphorylation of tau at both Thr 231 and Ser 262 is required for maximal inhibition of its binding to microtubules.	PHKG1 PRKCD	9.10e-05	9	56	2	9735171
Pubmed	HEB and E2A function as SMAD/FOXH1 cofactors.	TCF4 TCF12	1.14e-04	10	56	2	21828274
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	CPAMD8 PHLDB1 GPR137C BCAS3 CDK13 GALNT11 APMAP IGSF9B SYTL1 PBX1	1.18e-04	1489	56	10	28611215
Pubmed	A collection of cDNAs enriched in upper cortical layers of the embryonic mouse brain.	PHLDB1 MRC2 CNTN2	1.21e-04	59	56	3	15010206
Pubmed	Genetic regulation of mouse stem cells: identification of two keratinocyte stem cell regulatory loci.	TCF12 ADAM10	1.39e-04	11	56	2	14594209
Pubmed	Tau is phosphorylated by GSK-3 at several sites found in Alzheimer disease and its biological activity markedly inhibited only after it is prephosphorylated by A-kinase.	PHKG1 PRKCD	1.39e-04	11	56	2	9771888
Pubmed	Early construction of the thalamocortical axon pathway requires c-Jun N-terminal kinase signaling within the ventral forebrain.	NKX2-1 CNTN2	1.39e-04	11	56	2	34494344
Pubmed	PAF-AH Catalytic Subunits Modulate the Wnt Pathway in Developing GABAergic Neurons.	TCF4 CNTN2	1.66e-04	12	56	2	20725507
Pubmed	Involvement of aberrant glycosylation in phosphorylation of tau by cdk5 and GSK-3beta.	PHKG1 PRKCD	1.66e-04	12	56	2	12387894
Pubmed	Identification of two keratinocyte stem cell regulatory loci implicated in skin carcinogenesis.	TCF12 ADAM10	1.66e-04	12	56	2	12663500
Pubmed	New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry.	PHKG1 PRKCD	1.66e-04	12	56	2	9832145
Pubmed	HIV Nef, paxillin, and Pak1/2 regulate activation and secretion of TACE/ADAM10 proteases.	PRKCD ADAM10	1.96e-04	13	56	2	23317503
Pubmed	Differential interactions of Id proteins with basic-helix-loop-helix transcription factors.	TCF4 TCF12	1.96e-04	13	56	2	9242638
Pubmed	Rudhira/BCAS3 is essential for mouse development and cardiovascular patterning.	BCAS3 CNTN2	1.96e-04	13	56	2	29618843
Pubmed	E protein silencing by the leukemogenic AML1-ETO fusion protein.	TCF4 TCF12	2.29e-04	14	56	2	15333839
Pubmed	Slit2 activity in the migration of guidepost neurons shapes thalamic projections during development and evolution.	NKX2-1 CNTN2	3.41e-04	17	56	2	21435555
Pubmed	Dorsoventral patterning of the telencephalon is disrupted in the mouse mutant extra-toes(J).	NKX2-1 GRIK4	3.41e-04	17	56	2	10625551
Pubmed	Nell1-deficient mice have reduced expression of extracellular matrix proteins causing cranial and vertebral defects.	NKX2-1 MRC2 PRKCD PRKCSH	3.71e-04	210	56	4	16537572
Pubmed	OL-Protocadherin is essential for growth of striatal axons and thalamocortical projections.	NKX2-1 CNTN2	3.83e-04	18	56	2	17721516
Pubmed	TIF1gamma controls erythroid cell fate by regulating transcription elongation.	TCF4 TCF12	3.83e-04	18	56	2	20603019
Pubmed	Neural Stem Cells Direct Axon Guidance via Their Radial Fiber Scaffold.	NKX2-1 CNTN2	3.83e-04	18	56	2	32707082
Pubmed	Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.	RIPK1 BCAS3 MRC2 RYR1	3.98e-04	214	56	4	22199357
Pubmed	Pathfinding of corticothalamic axons relies on a rendezvous with thalamic projections.	NKX2-1 CNTN2	4.28e-04	19	56	2	23395374
Pubmed	ETO2 coordinates cellular proliferation and differentiation during erythropoiesis.	TCF4 TCF12	4.75e-04	20	56	2	16407974
Pubmed	A Highly Conserved Shh Enhancer Coordinates Hypothalamic and Craniofacial Development.	TCF4 NKX2-1	5.24e-04	21	56	2	33869166
Pubmed	The DNA Methyltransferase 1 (DNMT1) Controls the Shape and Dynamics of Migrating POA-Derived Interneurons Fated for the Murine Cerebral Cortex.	TCF4 NKX2-1	5.24e-04	21	56	2	29117290
Pubmed	Phylogenetic and expression analysis of the basic helix-loop-helix transcription factor gene family: genomic approach to cellular differentiation.	NCOA3 TCF4 TCF12	5.40e-04	98	56	3	18557763
Pubmed	The Rfx4 transcription factor modulates Shh signaling by regional control of ciliogenesis.	NKX2-1 CNTN2	5.76e-04	22	56	2	19887680
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	BTN3A3 PHLDB1 TENM3 PRKCSH ADD2	5.84e-04	421	56	5	36976175
Pubmed	A census of human transcription factors: function, expression and evolution.	HOXA13 NCOA3 TCF4 TCF12 NKX2-1 PBX1 RFX7	6.15e-04	908	56	7	19274049
Pubmed	Draxin from neocortical neurons controls the guidance of thalamocortical projections into the neocortex.	NKX2-1 CNTN2	6.30e-04	23	56	2	26659141
Pubmed	Pbx1/Pbx2 requirement for distal limb patterning is mediated by the hierarchical control of Hox gene spatial distribution and Shh expression.	HOXA13 PBX1	6.30e-04	23	56	2	16672333
Pubmed	FGF signalling generates ventral telencephalic cells independently of SHH.	NKX2-1 CNTN2	6.30e-04	23	56	2	16818446
Pubmed	TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation.	TCF4 TCF12 YTHDF2	7.36e-04	109	56	3	33554859
Pubmed	Transcription factor Tcf4 is the preferred heterodimerization partner for Olig2 in oligodendrocytes and required for differentiation.	TCF4 TCF12	7.46e-04	25	56	2	32266943
Pubmed	Loss of Gsx1 and Gsx2 function rescues distinct phenotypes in Dlx1/2 mutants.	NKX2-1 PBX1	7.46e-04	25	56	2	23042297
Pubmed	Foxp transcription factors suppress a non-pulmonary gene expression program to permit proper lung development.	HOXA13 NKX2-1	8.07e-04	26	56	2	27341756
Pubmed	Non-canonical Wnt Signaling through Ryk Regulates the Generation of Somatostatin- and Parvalbumin-Expressing Cortical Interneurons.	TCF4 NKX2-1	8.71e-04	27	56	2	31257105
Pubmed	Regulation of archicortical arealization by the transcription factor Zbtb20.	TENM3 GRIK4	9.37e-04	28	56	2	22689450
Pubmed	The Ciliopathy Gene Ftm/Rpgrip1l Controls Mouse Forebrain Patterning via Region-Specific Modulation of Hedgehog/Gli Signaling.	NKX2-1 CNTN2	1.01e-03	29	56	2	30692221
Pubmed	A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins.	TENM3 PRKCSH GALNT5 ADD2 IGSF3 FAM83H	1.03e-03	719	56	6	35337019
Pubmed	Control of developmentally primed erythroid genes by combinatorial co-repressor actions.	TCF4 TCF12	1.08e-03	30	56	2	26593974
Pubmed	Disruption of SoxB1-dependent Sonic hedgehog expression in the hypothalamus causes septo-optic dysplasia.	TCF4 NKX2-1	1.15e-03	31	56	2	22421044
Pubmed	Dlx1&2 and Mash1 transcription factors control MGE and CGE patterning and differentiation through parallel and overlapping pathways.	TCF4 NKX2-1 PBX1	1.22e-03	130	56	3	19386638
Pubmed	Molecular mapping of developing dorsal horn-enriched genes by microarray and dorsal/ventral subtractive screening.	TCF4 IGSF3	1.22e-03	32	56	2	16516881
Pubmed	Dlx1&2 and Mash1 transcription factors control striatal patterning and differentiation through parallel and overlapping pathways.	TCF4 NKX2-1 PBX1	1.34e-03	134	56	3	19030180
Pubmed	A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway.	RIPK1 TENM3 MRC2 FAM83H	1.44e-03	302	56	4	30561431
Interaction	TCF21 interactions	TCF4 TCF12 PBX1	1.34e-05	17	56	3	int:TCF21
GeneFamily	Polypeptide N-acetylgalactosaminyltransferases	GALNT11 GALNT12 GALNT5	9.53e-06	20	38	3	433
GeneFamily	Fibronectin type III domain containing	IL12RB1 FNDC3A IGSF9B CNTN2	3.45e-04	160	38	4	555
GeneFamily	Immunoglobulin like domain containing	HMCN2 IGSF9B CNTN2 IGSF3	6.99e-04	193	38	4	594
GeneFamily	Basic helix-loop-helix proteins	NCOA3 TCF4 TCF12	1.58e-03	110	38	3	420
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	HMCN2 IGSF9B CNTN2	4.65e-03	161	38	3	593
GeneFamily	Adenosine receptors\|V-set domain containing	BTN3A3 IGSF9B IGSF3	4.82e-03	163	38	3	590
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	IL12RB1 MRC2 KEL ADAM10	9.14e-03	394	38	4	471
CoexpressionAtlas	Ectoderm Differentiated Cells_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05	ILDR2 TCF4 PHLDB1 TCF12 BCAS3 FNDC3A SYTL1 PBX1 RFX7 ARSI ADD2	3.13e-05	967	55	11	PCBC_ratio_ECTO_vs_MESO-5_cfr-2X-p05
ToppCell	droplet-Lung-nan-3m-Lymphocytic-T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PHKG1 GPR137C GALNT12 IGSF9B SYTL1	2.31e-06	169	56	5	df2c9c706bfc9db2bc5726602a49f5f5a94e9481
ToppCell	droplet-Lung-nan-3m-Lymphocytic-Proliferating_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PHKG1 GPR137C GALNT12 IGSF9B SYTL1	2.31e-06	169	56	5	f6a6d2f614d60395ad9b867ff1cf59eba72b04ce
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TMEM86B KEL GALNT5 PBX1 ADD2	3.40e-06	183	56	5	b52d7683dc6652766e814ebe935c264ecd610c4b
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-hematologic\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TMEM86B KEL GALNT5 PBX1 ADD2	3.40e-06	183	56	5	1db466cf757813322db1cdcc0bf1d91c062fd9de
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-hematologic-erythrocytic\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TMEM86B KEL GALNT5 PBX1 ADD2	3.40e-06	183	56	5	1d77d8d8c8f78f43dd8864e76f294ee66d4942c2
ToppCell	COVID-19-Heart-Fib_2\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BNC2 TCF4 PHLDB1 HMCN2 MRC2	3.59e-06	185	56	5	8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d
ToppCell	10x5'v1-week_17-19-Hematopoietic-erythroid-mid_erythroid\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	MRC2 TMEM86B KEL GALNT5 ADD2	3.59e-06	185	56	5	e9059cefcdf0972ec90793b1dd34c3292b17a061
ToppCell	COVID-19-Heart-Fib_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BNC2 TCF4 PHLDB1 HMCN2 MRC2	3.88e-06	188	56	5	fe361215f4ba841aa5e1e581fb56f2f4d3ccd201
ToppCell	10x3'2.3-week_12-13-Hematopoietic-erythroid-mid_erythroid\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MRC2 TMEM86B KEL GALNT5 ADD2	4.41e-06	193	56	5	1e19f80c52833fb21a8d597a3ba2c4ff464c4559
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	BNC2 TCF4 MRC2 GRIK4 PBX1	4.41e-06	193	56	5	acad568621ed677031797b8c2e34dafea798d681
ToppCell	severe_influenza-RBC\|severe_influenza / disease group, cell group and cell class (v2)	MRC2 TMEM86B KEL PBX1 ADD2	4.41e-06	193	56	5	ffb0b3c2cce13b6891157f0fede2600f3938670e
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BNC2 PHLDB1 TENM3 MRC2 ARSI	4.75e-06	196	56	5	525d6c8a277364e624e7cc586275f8a891436b57
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	BNC2 TENM3 MRC2 GRIK4 PBX1	5.00e-06	198	56	5	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	COVID-19-lung-Fibroblast\|lung / Disease (COVID-19 only), tissue and cell type	BNC2 TENM3 MRC2 GRIK4 PBX1	5.00e-06	198	56	5	df3de77216f5c5d6141ec44d01c56b942f611838
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	BNC2 TCF4 TENM3 MRC2 PBX1	5.12e-06	199	56	5	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2\|Cerebellum / BrainAtlas - Mouse McCarroll V32	BNC2 MRC2 SYTL1 ARSI	1.92e-05	126	56	4	83f3540683b3b175b10af059ab8898c46eaccc13
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)\|Cerebellum / BrainAtlas - Mouse McCarroll V32	BNC2 MRC2 SYTL1 ARSI	1.92e-05	126	56	4	6d5075d659dac7b96e6857f8485a7d2c4105d685
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1-Endothelial_Tip.Dcn.Nnat_(Nnat)-\|Cerebellum / BrainAtlas - Mouse McCarroll V32	BNC2 MRC2 SYTL1 ARSI	1.92e-05	126	56	4	fd0001a0f3a0a4421f96fd21813c21cf6f01d40e
ToppCell	Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_2-Dcn_2_1\|Cerebellum / BrainAtlas - Mouse McCarroll V32	BNC2 MRC2 SYTL1 ARSI	1.92e-05	126	56	4	f20424f9baf3c4059cd6b701761e7595400fc47c
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TCF4 GRIK4 ARSI IGSF3	3.34e-05	145	56	4	78f5f4b96420c7f391e4d32a9ed151ed95fad90b
ToppCell	facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TENM3 HHIPL1 GALNT5 RYR1	4.22e-05	154	56	4	5ed64bbf603290e6dc34f81d145982690b89dd0d
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo1_Itga4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TCF4 GRIK4 ARSI IGSF3	4.33e-05	155	56	4	cba6f3f7742b4d5d54ad0a0ac0dd4016e73fe658
ToppCell	facs-Heart-Unknown-3m-Myeloid-monocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HHIPL1 C8B CNTN2 RYR1	4.55e-05	157	56	4	8d30d8e6fae93afcada6bd68799439335cd65b69
ToppCell	facs-Heart-Unknown-3m-Myeloid\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HHIPL1 C8B CNTN2 RYR1	4.55e-05	157	56	4	2ac4695d9e4ca8d4ba19c555e9a1d86ac8f398ab
ToppCell	facs-Heart-Unknown-3m-Myeloid-monocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HHIPL1 C8B CNTN2 RYR1	4.55e-05	157	56	4	8a393eece90fb9a1b7c356736bdb36277261fbd3
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM86B KEL ARSI ADD2	4.90e-05	160	56	4	56e6f4b82b5dc41c45f9d253c2db314a6f702b84
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM86B KEL ARSI ADD2	4.90e-05	160	56	4	bb1b966fb9e801db15e67d03e49db4609d6f935a
ToppCell	facs-Marrow-Granulocytes-18m-Hematologic\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TMEM86B KEL ARSI ADD2	5.02e-05	161	56	4	60f433eab9d5531bdf6aa86b0265f20b866b904c
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TENM3 GRIK4 HHIPL1 BEND2	5.27e-05	163	56	4	bbc078761c5043af13d9a6fcf3145a3e300bae5e
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TENM3 GRIK4 HHIPL1 BEND2	5.27e-05	163	56	4	8e32b6431e1862572663aa6ddc4ea299c6acc8a6
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Chat_Htr1f\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	TCF4 HMCN2 GRIK4 IGSF3	6.34e-05	171	56	4	f9ae7964a3740f559431125c17c660549798cccc
ToppCell	facs-Lung-EPCAM-18m-Lymphocytic-Regulatory_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL12RB1 GALNT12 PNLDC1 SYTL1	6.63e-05	173	56	4	82fa5ff6a00216a21a37fafeaf3e21e964c61d47
ToppCell	facs-Lung-EPCAM-18m-Lymphocytic-regulatory_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IL12RB1 GALNT12 PNLDC1 SYTL1	6.63e-05	173	56	4	13f67f61edb734ff846da92d41e81ec4670a2b66
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Hematopoietic-T_cells-ILCP\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ILDR2 IL12RB1 GRIK4 PNLDC1	6.94e-05	175	56	4	f2c3e0f728a43d6988e793c8a50c964f7447db82
ToppCell	droplet-Fat-SCAT-30m-Lymphocytic-T_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRYBA4 IL12RB1 GALNT12 FAM83H	7.25e-05	177	56	4	baf78a8dad55f124f56585f88b10b58c0269680f
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ILDR2 BNC2 GALNT12 SYTL1	7.74e-05	180	56	4	2ccc77d769d3ffd77ab3af45e4f192785b6db79c
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NCOA3 FNDC3A GRIK4 SYTL1	7.90e-05	181	56	4	6cdee2f56bc633b387b4dbbd78c624edbd712c24
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Lymphocytic_B-Plasma_Cell-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	NCOA3 FNDC3A GRIK4 SYTL1	7.90e-05	181	56	4	b75b8b025257bccfe661fd0f92ab284b2a9c12ee
ToppCell	10x3'2.3-week_14-16-Lymphocytic_NK-T_NK-mature_NK\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	CRYBA4 BNC2 APMAP FAM83H	8.25e-05	183	56	4	8746e6ecc6bf9e194cc9cdf9b07da63f0fcf8b5f
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D231\|Adult / Lineage, Cell type, age group and donor	BNC2 PHLDB1 HMCN2 PBX1	8.60e-05	185	56	4	fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804
ToppCell	PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	BNC2 TENM3 GALNT5 PBX1	8.78e-05	186	56	4	4d68ee3d32f7ef884faf402ef92b31b0eb4656f1
ToppCell	severe_influenza-RBC\|World / disease group, cell group and cell class (v2)	MRC2 TMEM86B KEL PBX1	8.96e-05	187	56	4	f846750575f318503d21ade30f5bfd2e1d4c84af
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	BNC2 TENM3 GRIK4 PBX1	8.96e-05	187	56	4	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6\|TCGA-Breast / Sample_Type by Project: Shred V9	BNC2 TCF4 GALNT5 ARSI	8.96e-05	187	56	4	a96495803ba13fcfadd1d83b3cf5774f3fed0a20
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ILDR2 BNC2 TENM3 IGSF9B	9.15e-05	188	56	4	b21e93a70583c30d05c0833cd3d4d4bca44a039e
ToppCell	Control-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	ILDR2 NCOA3 PHLDB1 BCAS3	9.15e-05	188	56	4	88b3415e33db81726dd29c1f50c886e057af50a0
ToppCell	COPD-Endothelial-VE_Capillary_A\|Endothelial / Disease state, Lineage and Cell class	ILDR2 NCOA3 PHLDB1 BCAS3	9.15e-05	188	56	4	1aa0e35b1c28ac847886fece16c3ef7fc6fcdd51
ToppCell	Influenza_Severe-RBC\|World / Disease group and Cell class	MRC2 TMEM86B KEL PBX1	9.15e-05	188	56	4	f0438e6a77ee1f0456cb65926685266fff470983
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ILDR2 BNC2 TENM3 IGSF9B	9.15e-05	188	56	4	874404a4fd9aa42873f6c53dc42da22d3b0fdb9e
ToppCell	Mesenchymal-myofibroblast_cell\|World / Lineage, Cell type, age group and donor	BNC2 TCF4 PHLDB1 GPR137C	9.34e-05	189	56	4	44e37f88137bb249933eb615235b2cf2ae7f3925
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 TENM3 MRC2 ARSI	9.34e-05	189	56	4	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 TENM3 MRC2 ARSI	9.34e-05	189	56	4	e9d5e858e320c6e9913c1ea6a54967d21eda605f
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte\|World / Lineage, cell class and subclass	MRC2 TMEM86B KEL ADD2	9.34e-05	189	56	4	826457adac7477102f86aceb97a8b77929b3e6f9
ToppCell	MatrixFB-Fibroblast-C\|MatrixFB / shred on cell class and cell subclass (v4)	ILDR2 BNC2 TENM3 PBX1	9.53e-05	190	56	4	d0106f7a21292f0b96ce4337ec3efbb1bd78dd0a
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells\|World / Lineage, cell class and subclass	MRC2 TMEM86B KEL ADD2	9.53e-05	190	56	4	6c7e016a9b425ee9418acd4fe96b9779fe7bd39a
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 TENM3 MRC2 ARSI	9.73e-05	191	56	4	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	BNC2 TENM3 GRIK4 PBX1	9.73e-05	191	56	4	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	severe_COVID-19-RBC\|World / disease group, cell group and cell class (v2)	MRC2 TMEM86B KEL PBX1	9.92e-05	192	56	4	1b4e28fd2e3d70ab48dbe96b280d35395889fbe2
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 TENM3 MRC2 ARSI	9.92e-05	192	56	4	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HMCN2 MRC2 PBX1 IGSF3	9.92e-05	192	56	4	29bee88b45e23f16543ffc7cc361bc5da5d16a2b
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	BNC2 TCF4 PHLDB1 MRC2	9.92e-05	192	56	4	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 TENM3 MRC2 ARSI	9.92e-05	192	56	4	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	BNC2 TENM3 GRIK4 PBX1	9.92e-05	192	56	4	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 TENM3 MRC2 ARSI	9.92e-05	192	56	4	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 TENM3 MRC2 ARSI	9.92e-05	192	56	4	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HMCN2 MRC2 PBX1 IGSF3	9.92e-05	192	56	4	cdc652dbfabe41b324fd85c1ed933d29fb73a49f
ToppCell	Influenza_Severe-RBC\|Influenza_Severe / Disease group and Cell class	MRC2 TMEM86B KEL PBX1	9.92e-05	192	56	4	f19b6da3fd98da1a76d2570137a8f73a3850ebcb
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 TENM3 MRC2 ARSI	9.92e-05	192	56	4	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 TENM3 MRC2 ARSI	1.01e-04	193	56	4	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	LV-01._Fibroblast_I\|LV / Chamber and Cluster_Paper	BNC2 TCF4 PHLDB1 MRC2	1.01e-04	193	56	4	dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell	RV-02._Fibroblast_II\|RV / Chamber and Cluster_Paper	BNC2 TCF4 PHLDB1 MRC2	1.03e-04	194	56	4	11c79a8c56ece42713b04b321982e41e239f07a5
ToppCell	LV-02._Fibroblast_II\|LV / Chamber and Cluster_Paper	BNC2 TCF4 PHLDB1 MRC2	1.03e-04	194	56	4	014d2feb5db2a6a35ef759761a41e466e108c3c1
ToppCell	COVID-19-Heart-Fib_2\|Heart / Disease (COVID-19 only), tissue and cell type	BNC2 PHLDB1 HMCN2 MRC2	1.03e-04	194	56	4	d91c9f2ec47319051fc398320693fddbe8bbd4d6
ToppCell	LPS-antiTNF-Stromal_mesenchymal\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 TENM3 MRC2 ARSI	1.03e-04	194	56	4	6e13549f697f7478b34fe71f7dd9d63c5d3db22e
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	BNC2 TENM3 MRC2 PBX1	1.03e-04	194	56	4	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	LA-02._Fibroblast_II\|LA / Chamber and Cluster_Paper	BNC2 TCF4 PHLDB1 MRC2	1.03e-04	194	56	4	234d1494c114cce77c619708bbcd8d5ce805f19b
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BNC2 PHLDB1 HMCN2 PBX1	1.05e-04	195	56	4	ff0aa455e9844a6d7ae57ff59fb6cea825cf1fc2
ToppCell	LA-02._Fibroblast_II\|World / Chamber and Cluster_Paper	BNC2 PHLDB1 HMCN2 MRC2	1.05e-04	195	56	4	a78b605b49acd8c9d68716266ca269dafcd910b9
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	BNC2 TENM3 GRIK4 PBX1	1.05e-04	195	56	4	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	10x3'2.3-week_14-16-Hematopoietic-erythroid-mid_erythroid\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	MRC2 TMEM86B KEL ADD2	1.05e-04	195	56	4	4759018a7c016cb2e3df5696f1e5f912c7c9ee17
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	BNC2 TCF4 GRIK4 PBX1	1.07e-04	196	56	4	1450cb69c5bf469e97c03bf1890f6f7c54165b8a
ToppCell	Children_(3_yrs)-Mesenchymal\|Children_(3_yrs) / Lineage, Cell type, age group and donor	BNC2 MRC2 GRIK4 PBX1	1.07e-04	196	56	4	bc94909f9b2dc08a59eef1914148b69720569c8f
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells\|Megakaryocytic-erythropoietic / Lineage, cell class and subclass	MRC2 TMEM86B KEL ADD2	1.07e-04	196	56	4	092caba6726d1acd409a8be335100764d0724e64
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	BNC2 TENM3 MRC2 PBX1	1.10e-04	197	56	4	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	PCW_13-14-Mesenchymal\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	BNC2 TCF4 MRC2 PBX1	1.10e-04	197	56	4	73a2085d2682d636726a5432d572ae2a3fbe1c3f
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	BNC2 TENM3 MRC2 PBX1	1.10e-04	197	56	4	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	BNC2 TCF4 TENM3 GRIK4	1.10e-04	197	56	4	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	Transverse-T_cell-CD8_T\|T_cell / Region, Cell class and subclass	BTN3A3 GALNT11 APMAP IGHV1-46	1.12e-04	198	56	4	3b0613171cc7d5320f0b525cc6836f21874b0505
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	BNC2 TCF4 GRIK4 PBX1	1.12e-04	198	56	4	17dc055e2a289496d9c5cdbf3297bdf906dc6d22
ToppCell	Caecum-(2)_B_cell-(21)_B_cell_IgG_Plasma\|Caecum / shred on region, Cell_type, and subtype	CRYBA4 NCOA3 TCF4 FNDC3A	1.12e-04	198	56	4	3893fcfc1de5937be3ccc7e545f711f2c95a2827
ToppCell	Caecum-B_cell-B_cell_IgG_Plasma\|Caecum / Region, Cell class and subclass	CRYBA4 NCOA3 TCF4 FNDC3A	1.12e-04	198	56	4	d8cb78b1763710a158cf22b59aebaa44afd2374c
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	BNC2 TCF4 TENM3 MRC2	1.12e-04	198	56	4	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	BNC2 TENM3 MRC2 ARSI	1.14e-04	199	56	4	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	PCW_10-12-Mesenchymal\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	BNC2 TCF4 MRC2 PBX1	1.14e-04	199	56	4	a09292de4c4447b8eee55d401808e43b817321cc
ToppCell	Influenza-Influenza_Severe-Others-RBC\|Influenza_Severe / Disease, condition lineage and cell class	CRYBA4 MRC2 TMEM86B PBX1	1.14e-04	199	56	4	da0fec0a492bc3827d9066d2590bcd466cd45564
ToppCell	Lung_Parenchyma-Severe-Hematopoietic-RBC-RBC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	TMEM86B KEL BEND2 ADD2	1.16e-04	200	56	4	b5f2892bc45fda5ae05e269b840305a608a07c37
ToppCell	Lung_Parenchyma-Severe-Hematopoietic-RBC\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	TMEM86B KEL BEND2 ADD2	1.16e-04	200	56	4	9ce1f91991637fc3af0f6a80a85e1a44276fe412
ToppCell	Lung_Parenchyma-Severe-Hematopoietic\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	TMEM86B KEL BEND2 ADD2	1.16e-04	200	56	4	fdf3e60cf94f398a56c0fa72813d0459f5ce081b
ToppCell	Parenchymal-NucSeq-Stromal\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BNC2 TCF4 TENM3 GRIK4	1.16e-04	200	56	4	cf433f9b43d7db07acaf70e060f8f77c974e72f3
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	BNC2 TCF4 TENM3 GRIK4	1.16e-04	200	56	4	cae972324d1dfea6efeaf6013f265c7c6bb48db4
Computational	Neighborhood of DDX11	CRYBA4 CDK13 IGSF9B PRKCSH CNTN2	1.03e-04	156	33	5	MORF_DDX11
Computational	Neighborhood of CASP2	CRYBA4 IGSF9B PRKCSH ADD2	2.63e-04	103	33	4	MORF_CASP2
Computational	Neighborhood of FDXR	CRYBA4 CDK13 IGSF9B PRKCSH CNTN2	5.77e-04	226	33	5	MORF_FDXR
Computational	Genes in the cancer module 15.	CRYBA4 TCF12 PRKCD TDG C8B ADAM10 ADD2	7.47e-04	509	33	7	MODULE_16
Computational	Neighborhood of MT4	CRYBA4 CDK13 PRKCSH CNTN2 ADD2	8.63e-04	247	33	5	MORF_MT4
Computational	Neighborhood of PML	CRYBA4 IGSF9B PRKCSH CNTN2	9.59e-04	145	33	4	MORF_PML
Computational	Neighborhood of RAGE	CRYBA4 IGSF9B CNTN2 ADD2	1.04e-03	148	33	4	MORF_RAGE
Computational	Neighborhood of ORC1L	CRYBA4 IGSF9B PRKCSH	1.20e-03	69	33	3	MORF_ORC1L
Computational	Neighborhood of FANCG	CRYBA4 CDK13 IGSF9B PRKCSH	1.62e-03	167	33	4	MORF_FANCG
Computational	Neighborhood of ARAF1	CACTIN IGSF9B PRKCSH	1.71e-03	78	33	3	MORF_ARAF1
Disease	Pitt-Hopkins syndrome (implicated_via_orthology)	TCF4 TCF12	9.85e-06	3	54	2	DOID:0060488 (implicated_via_orthology)
Disease	cataract (biomarker_via_orthology)	CRYBA4 ADAM10	2.53e-04	13	54	2	DOID:83 (biomarker_via_orthology)
Disease	Child Behaviour Checklist assessment	RIPK1 TENM3	4.94e-04	18	54	2	EFO_0005661
Disease	treatment-resistant hypertension	BNC2 TCF4 BCAS3	1.06e-03	109	54	3	EFO_1002006

Protein segments in the cluster

Peptide	Gene	Start	Entry
GESAFSGIPNGQWMT	TDG	371	Q13569
TPENGYWTMGLTDGN	BTN3A3	426	O00478
TTAEPGFMGTWQNAD	BNC2	86	Q6ZN30
LSWAAGMGGQYGNPL	ADAM10	11	O14672
GENVAWGLSGQYSTM	ARSI	196	Q5FYB1
SLEPGWYSAMAQGQA	GLCE	436	O94923
DNIRPSSSGGYWVGM	APMAP	306	Q9HDC9
GYSDGMQVWSIPISG	BCAS3	96	Q9H6U6
MHGQTWTSPAQGPGY	CDK13	1476	Q14004
QDTMRNSASGPGWYG	NKX2-1	101	P43699
SQMYSPQGISANGGW	PBX1	391	P40424
GTGQWQYSEICMGHG	HHIPL1	511	Q96JK4
DMQDNSGTYGKIWEG	PRKCD	326	Q05655
KGNYSSQSGMIPGSW	EDRF1	666	Q3B7T1
SAMKYEQGTGCWQGP	PRKCSH	461	P14314
VSPGEDTYLLAGGWM	HMCN2	2401	Q8NDA2
WMGIINPSGGSTSYA	IGHV1-46	66	P01743
PWSSSSGMNQPGYAG	TCF4	226	P15884
SLPNSQSLGWYGTMT	GPR137C	371	Q8N3F9
GMPWNFISGGAESTN	BEND2	231	Q8NDZ0
GLPEGYMFIWNGEVS	FKBP9P1	51	Q75LS8
GQYDSGMDIWGGENL	GALNT11	341	Q8NCW6
DLWSSSNGMSQPGFG	TCF12	236	Q99081
TGWPGTNTTASLGMY	MRC2	96	Q9UBG0
MWLDRDGTVQPGSSY	IGSF3	461	O75054
GTYDPGLDVWGGENM	GALNT5	686	Q7Z7M9
GSNGNKWEMIYSGAT	FNDC3A	606	Q9Y2H6
PAFQSGGEEGLWMSN	CPAMD8	1866	Q8IZJ3
GSYDTGMEVWGGENL	GALNT12	326	Q8IXK2
WTPMSREYQNGDGFG	CNTN2	731	Q02246
YPSLQAMGWEGNEVG	CRYBA4	126	P53673
NISVGTNGTTMYWPA	IL12RB1	346	P42701
GWGEEYMGYTNTDNP	CACTIN	186	Q8WUQ7
AMVEAGAGTGWTVYP	MT-CO1	116	P00395
VDMDGSSGTYWPVNS	FAM83H	86	Q6ZRV2
GVYGVPEANGTWTGM	GRIK4	471	Q16099
CYMVWGGDFVSPGQQ	RYR1	1491	P21817
MDQYWGIGSLASGIN	C8B	166	P07358
MIMSGNYQFGSPEWD	PHKG1	241	Q16816
TGSSYGLQVPWMDST	SYTL1	516	Q8IYJ3
YGPMELGQSLWEAEG	SNHG12	41	Q9BXW3
EGDWMTLPGITGFQA	PNLDC1	166	Q8NA58
IYQSSEMKGWPSGNL	NCOA3	1356	Q9Y6Q9
SQGLGMGPVEESWFA	RIPK1	346	Q13546
WIEPTVMFLYDNGGG	HOXA13	11	P31271
EVGSVQWAGSTFGPM	ADD2	341	P35612
VTGWGTLYMNGSFPV	TMPRSS11B	306	Q86T26
SMTTANVSWEPGYDG	IGSF9B	521	Q9UPX0
DLESNPDYWSGVMGG	ILDR2	366	Q71H61
YMTFVQATSSGGGWP	SPATA20	151	Q8TB22
LQGYELDASNMGGWT	TENM3	1101	Q9P273
AGFLWVMSPSGGYTQ	TMEM86B	61	Q8N661
EWMNNGYSGVGNSSV	RFX7	966	Q2KHR2
WYQELMAGLGTGPAA	PHLDB1	926	Q86UU1
SMQPWNPGYSSEGAT	RWDD2B	6	P57060
GEAAWSTGGDTAMPY	YTHDF2	71	Q9Y5A9
QAGGMGTLWSQESTP	KEL	16	P23276